Veracyte Ownership | Who Owns Veracyte?

Overview Forecast RevenueFinancials Chart Transcripts

Veracyte Ownership Summary

Veracyte is owned by 71.61% institutional investors, 0.41% insiders, and 27.97% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 16.68% of VCYT shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.97% of its assets in Veracyte shares.

VCYT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Veracyte	71.61%	0.41%	27.97%
Sector	Healthcare Stocks	232.64%	10.66%	-143.30%
Industry	Biotech Stocks	382.13%	10.41%	-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	13.13M	16.68%	$552.72M
Vanguard group	8.50M	10.80%	$358.02M
Blackrock	7.79M	10.42%	$168.88M
Artisan partners limited partnership	7.37M	9.42%	$253.03M
Fmr	6.80M	8.69%	$233.30M
State street	4.20M	5.37%	$144.17M
Ark investment management	3.89M	4.94%	$163.67M
Wellington management group llp	3.37M	4.31%	$115.80M
Dimensional fund advisors lp	2.80M	3.56%	$117.90M
Arrowmark colorado	2.55M	3.25%	$87.40M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Palisades investment partners	162.04K	2.58%	$6.82M
Perkins capital management	75.43K	2.52%	$3.18M
Iron triangle partners lp	485.00K	2.37%	$16.65M
Silverarc capital management	357.56K	2.09%	$15.05M
Arrowmark colorado	2.55M	1.62%	$87.40M
Summit creek advisors	238.52K	1.58%	$10.04M
Ark investment management	3.89M	1.09%	$163.67M
Efg asset management (north america)	219.98K	0.98%	$7.56M
Oberweis asset management inc/	721.69K	0.95%	$24.78M
Granite investment partners	351.04K	0.88%	$14.78M

Top Buyers

Holder	Shares	% Assets	Change
Fuller & thaler asset management	1.38M	0.20%	1.38M
Champlain investment partners	1.17M	0.30%	1.17M
Artisan partners limited partnership	7.37M	0.36%	1.05M
State street	4.20M	0.01%	1.03M
Fred alger management	767.48K	0.10%	767.48K

Top Sellers

Holder	Shares	% Assets	Change
Driehaus capital management	-	-	-1.35M
Fmr	6.80M	0.01%	-1.31M
Qube research	12.71K	0.00%	-971.07K
Fiera capital	-	-	-625.54K
Ark investment management	3.89M	1.09%	-578.23K

New Positions

Holder	Shares	% Assets	Change	Value
Fuller & thaler asset management	1.38M	0.20%	1.38M	$58.16M
Champlain investment partners	1.17M	0.30%	1.17M	$40.06M
Fred alger management	767.48K	0.10%	767.48K	$26.35M
Iron triangle partners lp	485.00K	2.37%	485.00K	$16.65M
Alyeska investment group	308.05K	0.03%	308.05K	$10.58M

Sold Out

Holder	Change
Newedge advisors	-2.00
Global financial private client	-5.00
Kohmann bosshard financial services	-6.00
Ronald blue trust	-12.00
Opal wealth advisors	-13.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	226	-24.16%	56,376,420	-37.19%	71	0.54%	121	-27.11%	77	-11.49%
Sep 30, 2025	283	5.99%	88,589,496	7.86%	113	1.03%	161	21.97%	83	-15.31%
Jun 30, 2025	273	-5.21%	85,426,396	1.00%	109	0.93%	138	1.47%	98	-8.41%
Mar 31, 2025	9	-97.20%	3,530,599	-95.70%	4	0.04%	5	-96.84%	3	-97.41%
Dec 31, 2024	301	2.73%	77,106,580	-5.52%	100	0.89%	145	-9.94%	109	22.47%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Small-Cap ETF	4.75M	5.97%	1.77K
Vanguard US Total Market Shares ETF	2.46M	3.16%	2.69K
Vanguard Total Stock Mkt Idx Inv	2.49M	3.14%	5.73K
ARK Disruptive Innovation Full Composite	2.47M	3.13%	-491.37K
State Street® SPDR® S&P® Biotech ETF	1.96M	2.46%	29.47K
First Trust NYSE Arca Biotech ETF	1.92M	2.41%	-
iShares Russell 2000 ETF	1.90M	2.40%	-15.56K
ARK Innovation ETF	1.89M	2.37%	-26.17K
Vanguard Small Cap Index	1.79M	2.26%	3.82K
Vanguard Explorer Inv	1.61M	2.03%	-902.93K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 04, 2026	Chambers Rebecca	Chief Financial Officer	Sell	$156.41K
Mar 04, 2026	Chambers Rebecca	Chief Financial Officer	Sell	$506.46K
Mar 04, 2026	Stapley Marc	Chief Executive Officer	Sell	$953.37K
Mar 04, 2026	Stapley Marc	Chief Executive Officer	Sell	$684.23K
Mar 04, 2026	Leite John	Chief Commercial Officer-CLIA	Sell	$185.08K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	8
2025 Q4	-	32
2025 Q3	-	2
2025 Q2	-	3
2025 Q1	-	12

VCYT Ownership FAQ

Who Owns Veracyte?

Veracyte shareholders are primarily institutional investors at 71.61%, followed by 0.41% insiders and 27.98% retail investors. The average institutional ownership in Veracyte's industry, Biotech Stocks , is 382.13%, which Veracyte falls below.

Who owns the most shares of Veracyte?

Veracyte’s largest shareholders are Blackrock funding, inc. /de (13.13M shares, 16.68%), Vanguard group (8.5M shares, 10.80%), and Blackrock (7.79M shares, 10.42%). Together, they hold 37.90% of Veracyte’s total shares outstanding.

Does Blackrock own Veracyte?

Yes, BlackRock owns 10.42% of Veracyte, totaling 7.79M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 168.88M$. In the last quarter, BlackRock increased its holdings by 581.69K shares, a 8.07% change.

Who is Veracyte’s biggest shareholder by percentage of total assets invested?

Palisades investment partners is Veracyte’s biggest shareholder by percentage of total assets invested, with 2.58% of its assets in 162.04K Veracyte shares, valued at 6.82M$.

Who is the top mutual fund holder of Veracyte shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Veracyte shares, with 5.97% of its total shares outstanding invested in 4.75M Veracyte shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools